Home / Business To Business / Corporate Or Business Office / Salt Lake City / GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc.
One of 265 corporate or business office listings in Salt Lake City.
About GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc. is a corporate or business office in the business to business sector, based in Salt Lake City, UT. Its recorded address is 675 Arapeen Dr Ste 302, 84108. The listing includes a telephone number, an official website. It is one of 265 corporate or business office listings tracked in Salt Lake City; the nearest comparable listing is Progenitor Life Sciences LLC, within walking distance.
- Address
- 675 Arapeen Dr Ste 302, Salt Lake City, UT, 84108
- Phone
- 8016493999
- Website
- glycomira.com
Questions
Where is GlycoMira Therapeutics, Inc. located?
675 Arapeen Dr Ste 302, Salt Lake City, UT, 84108
How do I contact GlycoMira Therapeutics, Inc.?
8016493999 · http://www.glycomira.com/
What type of business is GlycoMira Therapeutics, Inc.?
GlycoMira Therapeutics, Inc. is a corporate or business office (business to business) in Salt Lake City.
Nearby corporate or business office
- Progenitor Life Sciences LLCSalt Lake City0.0 km
- Echelon Biosciences IncSalt Lake City0.0 km
- NeuroImaging and Biotechnology LaboratorySalt Lake City0.2 km
- 3HelixSalt Lake City0.3 km
- ActavisSalt Lake City0.3 km
- Teva Legacy Actavis EastSalt Lake City0.3 km
- Q TherapeuticsSalt Lake City0.5 km
- Blackrock NeurotechSalt Lake City0.5 km
- BioFire DiagnosticsSalt Lake City0.6 km
- MyrexisSalt Lake City0.9 km
- Huntsman CorpSalt Lake City0.7 km
- VA Regional OfficeSalt Lake City0.9 km
- Sorenson Impact CenterSalt Lake City1.6 km
- Langvardt Design GroupSalt Lake City2.3 km
- Glen Canyon InstituteSalt Lake City2.8 km
Cite this page
“GlycoMira Therapeutics, Inc., Salt Lake City — business.wiki, retrieved August 2026.” Facts on this page come from openly licensed data (Overture Maps Foundation) and are refreshed with each monthly release; sourcing is documented on the methodology page.